Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Activate Immunotherapy

Latest From Activate Immunotherapy

VC Roundup: Moderna Seeks Another Record-Breaking Raise; Arcus Emerges From Stealth Mode

Having raised a precedent-setting $450m venture capital round in January 2015, Moderna is well on its way to a planned $600m additional fundraising. The privately held company is keeping quiet about what it's doing with all that cash. Tioma, Nutrina and Avelas are among other firms receiving VC financing.

Commercial Business Strategies

FDA Advisory Panel To Discuss Vaccines Made From Human Tumor Cell Lines

The Sept. 19 meeting of FDA’s Vaccines and Related Biological Products Advisory Committee comes as several whole-cell cancer vaccines are in Phase III trials.


Gene Logic appoints Norrie Russell as president

Gene Logic, part of the Indian genomics services company, Ocimum Biosolutions, has appointed Dr Norrie Russell as president. Dr Russell, who comes with more than 30 years of experience in drug discovery, has previously held leadership positions with NovaRx, Invitrogen, Aviva Biosciences and Lynx Therapeutics. He has also worked for AstraZeneca, where he was global head, biological science and technology.

Serbia to participate in Phase III NSCLC vaccine trial

Serbia is set to be the first European country to participate in NovaRx's pivotal Phase III clinical trial of its lead product candidate, Lucanix (belagenpumatucel-L), for the treatment of advanced non-small cell lung cancer (NSCLC).

Cancer Canada
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • NovaRx Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Activate Immunotherapy
  • Senior Management
  • Justin M Murdock, CEO
    Fakhrai Habib, PhD, CSO
    Todd M Binder, COO
    Stella M Sung, PhD, CBO
  • Contact Info
  • Activate Immunotherapy
    Phone: (858) 552-8600
    6828 Nancy Ridge Dr.
    Ste. 100
    San Diego, CA 92121